98 related articles for article (PubMed ID: 9884310)
1. Aldose reductase catalyzes the oxidation of naphthalene-1, 2-dihydrodiol for the formation of ortho-naphthoquinone.
Sugiyama K; Wang TC; Simpson JT; Rodriguez L; Kador PF; Sato S
Drug Metab Dispos; 1999 Jan; 27(1):60-7. PubMed ID: 9884310
[TBL] [Abstract][Full Text] [Related]
2. Prevention of naphthalene-1,2-dihydrodiol-induced lens protein modifications by structurally diverse aldose reductase inhibitors.
Sato S; Sugiyama K; Lee YS; Kador PF
Exp Eye Res; 1999 May; 68(5):601-8. PubMed ID: 10328974
[TBL] [Abstract][Full Text] [Related]
3. Aldose reductase the major protein associated with naphthalene dihydrodiol dehydrogenase activity in rat lens.
Sato S
Invest Ophthalmol Vis Sci; 1993 Oct; 34(11):3172-8. PubMed ID: 8407226
[TBL] [Abstract][Full Text] [Related]
4. Involvement of aldose reductase in naphthalene cataract.
Lee AY; Chung SS
Invest Ophthalmol Vis Sci; 1998 Jan; 39(1):193-7. PubMed ID: 9430562
[TBL] [Abstract][Full Text] [Related]
5. Effect of aldose reductase inhibitors on naphthalene cataract formation in the rat.
Tao RV; Takahashi Y; Kador PF
Invest Ophthalmol Vis Sci; 1991 Apr; 32(5):1630-7. PubMed ID: 1901836
[TBL] [Abstract][Full Text] [Related]
6. Aldose reductase as dihydrodiol dehydrogenase. Naphthoquinone formation by rat lens aldose reductase.
Sato S; Sugiyama K; Carper D
Adv Exp Med Biol; 1997; 414():499-505. PubMed ID: 9059655
[No Abstract] [Full Text] [Related]
7. Differences in the susceptibility of various aldose reductases to inhibition. II.
Kador PF; Kinoshita JH; Tung WH; Chylack LT
Invest Ophthalmol Vis Sci; 1980 Aug; 19(8):980-2. PubMed ID: 6773903
[TBL] [Abstract][Full Text] [Related]
8. [Regulation of crystalline lens aldose reductase activity. Nonhyperbolic oxidation kinetics of NADPH by glucose].
Vartanov SS; Pavlov AR; Iaropolov AI
Biokhimiia; 1990 Nov; 55(11):2046-57. PubMed ID: 2128191
[TBL] [Abstract][Full Text] [Related]
9. Ascorbate free radical reductase and ascorbate redox cycle in the human lens.
Bando M; Obazawa H
Jpn J Ophthalmol; 1988; 32(2):176-86. PubMed ID: 3184551
[TBL] [Abstract][Full Text] [Related]
10. Glyceraldehyde-3-phosphate dehydrogenase as a quinone reductase in the suppression of 1,2-naphthoquinone protein adduct formation.
Miura T; Shinkai Y; Hirose R; Iwamoto N; Cho AK; Kumagai Y
Free Radic Biol Med; 2011 Dec; 51(11):2082-9. PubMed ID: 21963991
[TBL] [Abstract][Full Text] [Related]
11. Effect of dietary taurine supplementation on GSH and NAD(P)-redox status, lipid peroxidation, and energy metabolism in diabetic precataractous lens.
Obrosova IG; Stevens MJ
Invest Ophthalmol Vis Sci; 1999 Mar; 40(3):680-8. PubMed ID: 10067971
[TBL] [Abstract][Full Text] [Related]
12. Regulation of lens aldose reductase activity by nitric oxide.
Srivastava S; Tammali R; Chandra D; Greer DA; Ramana KV; Bhatnagar A; Srivastava SK
Exp Eye Res; 2005 Dec; 81(6):664-72. PubMed ID: 15967436
[TBL] [Abstract][Full Text] [Related]
13. Method for isolating tight-binding inhibitors of rat lens aldose reductase.
Sun G; Ma Y; Gao X; König S; Fales HM; Kador PF
Exp Eye Res; 2004 Dec; 79(6):919-26. PubMed ID: 15642330
[TBL] [Abstract][Full Text] [Related]
14. Effect of curcumin on galactose-induced cataractogenesis in rats.
Suryanarayana P; Krishnaswamy K; Reddy GB
Mol Vis; 2003 Jun; 9():223-30. PubMed ID: 12802258
[TBL] [Abstract][Full Text] [Related]
15. Biochemical and morphological changes during development of sugar cataract in Otsuka Long-Evans Tokushima fatty (OLETF) rat.
Kubo E; Maekawa K; Tanimoto T; Fujisawa S; Akagi Y
Exp Eye Res; 2001 Sep; 73(3):375-81. PubMed ID: 11520112
[TBL] [Abstract][Full Text] [Related]
16. A new approach against sugar cataract through aldose reductase inhibitors.
Banditelli S; Boldrini E; Vilardo PG; Cecconi I; Cappiello M; Dal Monte M; Marini I; Del Corso A; Mura U
Exp Eye Res; 1999 Nov; 69(5):533-8. PubMed ID: 10548473
[TBL] [Abstract][Full Text] [Related]
17. Rat lens aldose reductase inhibitory constituents of Nelumbo nucifera stamens.
Lim SS; Jung YJ; Hyun SK; Lee YS; Choi JS
Phytother Res; 2006 Oct; 20(10):825-30. PubMed ID: 16881021
[TBL] [Abstract][Full Text] [Related]
18. Lens aldose reductase in diabetic and galactosemic cataracts.
Parmar NS; Ghosh MN
Indian J Physiol Pharmacol; 1981; 25(3):193-200. PubMed ID: 6795119
[No Abstract] [Full Text] [Related]
19. 2-Chloro-1,4-naphthoquinone derivative of quercetin as an inhibitor of aldose reductase and anti-inflammatory agent.
Milackova I; Prnova MS; Majekova M; Sotnikova R; Stasko M; Kovacikova L; Banerjee S; Veverka M; Stefek M
J Enzyme Inhib Med Chem; 2015 Feb; 30(1):107-13. PubMed ID: 24666303
[TBL] [Abstract][Full Text] [Related]
20. The possible mechanism of naphthalene cataract in rat and its prevention by an aldose reductase inhibitor (ALO1576).
Xu GT; Zigler JS; Lou MF
Exp Eye Res; 1992 Jan; 54(1):63-72. PubMed ID: 1541342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
